icrf 198 has been researched along with edetic acid in 2 studies
| Studies (icrf 198) | Trials (icrf 198) | Recent Studies (post-2010) (icrf 198) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
|---|---|---|---|---|---|
| 24 | 0 | 4 | 27,553 | 629 | 3,970 |
| Protein | Taxonomy | icrf 198 (IC50) | edetic acid (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
| Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasinoff, BB | 1 |
| Thomas, C; Vile, GF; Winterbourn, CC | 1 |
2 other study(ies) available for icrf 198 and edetic acid
| Article | Year |
|---|---|
NADPH-cytochrome-P450 reductase promotes hydroxyl radical production by the iron complex of ADR-925, the hydrolysis product of ICRF-187 (dexrazoxane).
Topics: Animals; Catalase; Chelating Agents; Edetic Acid; Electron Spin Resonance Spectroscopy; Ethylenediamines; Glycine; Hydroxyl Radical; Iron Chelating Agents; Models, Chemical; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Rats; Razoxane; Spectrophotometry, Ultraviolet | 1995 |
The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Dimethyl Sulfoxide; Doxorubicin; Edetic Acid; Ethylenediamines; Ferric Compounds; Glycine; Hydrogen Peroxide; Hydrolysis; Hydroxides; Hydroxyl Radical; Iron; Kinetics; Oxidation-Reduction; Paraquat; Razoxane; Superoxides; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase | 1993 |